| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.53▼ | 1.52▼ | 1.51▲ | 1.47▲ | 1.78▼ |
| MA10 | 1.51▲ | 1.48▲ | 1.48▲ | 1.55▼ | 2.15▼ |
| MA20 | 1.48▲ | 1.47▲ | 1.49▲ | 1.74▼ | 2.31▼ |
| MA50 | 1.49▲ | 1.53▼ | 1.56▼ | 2.20▼ | 2.35▼ |
| MA100 | 1.58▼ | 1.66▼ | 1.74▼ | 2.34▼ | 2.71▼ |
| MA200 | 1.70▼ | 1.93▼ | 2.08▼ | 2.19▼ | 5.21▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.011▲ | 0.015▲ | 0.016▲ | -0.008▼ | -0.114▼ |
| RSI | 53.859▲ | 52.769▲ | 50.817▲ | 33.236▼ | 32.162▼ |
| STOCH | 95.139▲ | 80.052▲ | 63.386 | 10.648▼ | 8.392▼ |
| WILL %R | -26.923 | -26.923 | -26.923 | -87.487▼ | -92.414▼ |
| CCI | 40.733 | 85.859 | 103.415▲ | -75.550 | -164.222▼ |
|
Wednesday, November 19, 2025 09:00 AM
Century Therapeutics, Inc. (NASDAQ: IPSC) has unveiled its first program targeting Type 1 diabetes, introducing an engineered cell therapy designed to restore natural insulin production without the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/11/25 | 1.42 | 1.55 | 1.42 | 1.51 | 58,155 |
| 20/11/25 | 1.45 | 1.50 | 1.40 | 1.41 | 54,611 |
| 19/11/25 | 1.54 | 1.615 | 1.42 | 1.43 | 53,815 |
| 18/11/25 | 1.46 | 1.59 | 1.45 | 1.53 | 66,335 |
| 17/11/25 | 1.53 | 1.56 | 1.41 | 1.46 | 139,552 |
| 14/11/25 | 1.57 | 1.70 | 1.41 | 1.52 | 183,434 |
| 13/11/25 | 1.71 | 1.71 | 1.58 | 1.58 | 56,287 |
| 12/11/25 | 1.75 | 1.7702 | 1.69 | 1.71 | 33,490 |
| 11/11/25 | 1.51 | 1.7896 | 1.51 | 1.73 | 56,970 |
| 10/11/25 | 1.80 | 2.2791 | 1.60 | 1.61 | 379,552 |
|
|
||||
|
|
||||
|
|